Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 11, 2012, Pages 1279-1285

  Sordal, Terje ^a   Grob, Paul ^b   Verhoeven, Carole ^b  

^a Medicus Norway   (Norway)

^b NV ORGANON   (Netherlands)

Author keywords

17 estradiol; Bone mineral density; ethinylestradiol; levonorgestrel; nomegestrol acetate; oral contraceptive

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL; LEVONORGESTREL; NOMEGESTROL ACETATE;

ADULT; ARTICLE; BONE DENSITY; COMPARATIVE STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HIP; HUMAN; LUMBAR SPINE; NORWAY; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM;

EID: 84868315877     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01498.x     Document Type: Article

References (35)

1. Martins SL, Curtis KM, Glasier AF,. Combined hormonal contraception and bone health: a systematic review. Contraception. 2006; 73: 445-69.
2. Lopez LM, Grimes DA, Schulz KF, Curtis KM,. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev. 2011;(7): CD006033.
3. Prior JC, Kirkland SA, Joseph L, Kreiger N, Murray TM, Hanley DA, et al,. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ. 2001; 165: 1023-9.
4. Kleerekoper M, Brienza RS, Schultz LR, Johnson CC,. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Arch Intern Med. 1991; 151: 1971-6.
5. Laitinen K, Valimaki M, Keto P,. Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women. Calcif Tissue Int. 1991; 48: 224-31.
6. Pasco JA, Kotowicz MA, Henry MJ, Panahi S, Seeman E, Nicholson GC,. Oral contraceptives and bone mineral density: a population-based study. Am J Obstet Gynecol. 2000; 182: 265-9.
7. Sultana S, Choudhury S, Choudhury SA,. Effect of combined oral contraceptives on bone mineral density in pre and postmenopausal women. Mymensingh Med J. 2002; 11: 12-4.
8. Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P,. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception. Contraception. 2002; 65: 407-10.
9. Reed SD, Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM,. Longitudinal changes in bone density in relation to oral contraceptive use. Contraception. 2003; 68: 177-82.
10. Wei S, Jones G, Thomson R, Dwyer T, Venn A,. Oral contraceptive use and bone mass in women aged 26-36 years. Osteoporos Int. 2011; 22: 351-5.
11. Scholes D, Hubbard RA, Ichikawa LE, LaCroix AZ, Spangler L, Beasley JM, et al,. Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation. J Clin Endocrinol Metab. 2011; 96: E1380-7.
12. Scholes D, Ichikawa L, LaCroix AZ, Spangler L, Beasley JM, Reed S, et al,. Oral contraceptive use and bone density in adolescent and young adult women. Contraception. 2010; 81: 35-40.
13. Duijkers I, Klipping C, Grob P, Korver T,. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care 2010; 15: 314-25.
14. Mansour D, Verhoeven C, Sommer W, Weisberg E, Taneepanichskul S, Melis GB, et al,. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. Eur J Contracept Reprod Health Care. 2011; 16: 430-43.
15. Lindberg UB, Crona N, Stigendal L, Teger-Nilsson AC, Silfverstolpe G,. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. Thromb Haemost. 1989; 61: 65-9.
16. Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H,. Effect of four oral contraceptives on hemostatic parameters. Contraception. 2004; 70: 97-106.
17. Fruzzetti F, Bitzer J,. Review of clinical experience with estradiol in combined oral contraceptives. Contraception. 2010; 81: 8-15.
18. Gaussem P, Alhenc-Gelas M, Thomas JL, Bachelot-Loza C, Remones V, Ali FD, et al,. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study. Thromb Haemost. 2011; 105: 560-7.
19. Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer W, et al,. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care. 2011; 16: 444-57.
20. Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W,. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel. Drugs R D. 2011; 11: 159-70.
21. Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women. London: European Medicines Agency, 2005. Available at: http://www.ema.europa.eu/docs/en-GB/docu-ment- library/Scientific-guideline/2009/09/WC500003349.pdf
22. Tang OS, Tang G, Yip P, Li B, Fan S,. Long-term depot-medroxyprogesterone acetate and bone mineral density. Contraception. 1999; 59: 25-9.
23. Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y,. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age. Contraception. 2011; 83: 218-22.
24. Wei S, Venn A, Ding C, Foley S, Laslett L, Jones G,. The association between oral contraceptive use, bone mineral density and fractures in women aged 50-80 years. Contraception. 2011; 84: 357-62.
25. Beerthuizen R, van Beek A, Massai R, Makarainen L, Hout J, Bennink HC,. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod. 2000; 15: 118-22.
26. Endrikat J, Mih E, Dusterberg B, Land K, Gerlinger C, Schmidt W, et al,. A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception. 2004; 69: 179-87.
27. Massai R, Makarainen L, Kuukankorpi A, Klipping C, Duijkers I, Dieben T,. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women. Hum Reprod. 2005; 20: 2764-8.
28. Wei S, Winzenberg T, Laslett LL, Venn A, Jones G,. Oral contraceptive use and bone. Curr Osteoporos Rep. 2011; 9: 6-11.
29. Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A,. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol. 2001; 98: 576-82.
30. Banks E, Berrington A, Casabonne D,. Overview of the relationship between use of progestogen-only contraceptives and bone mineral density. BJOG. 2001; 108: 1214-21.
31. Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K,. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors. Contraception. 1997; 56: 1-3.
32. Turner RT, Riggs BL, Spelsberg TC,. Skeletal effects of estrogen. Endocr Rev. 1994; 15: 275-300.
33. Gambacciani M, Monteleone P, Ciaponi M, Sacco A, Genazzani AR,. Effects of oral contraceptives on bone mineral density. Treat Endocrinol. 2004; 3: 191-6.
34. Agostino H, Di Meglio G,. Low-dose oral contraceptives in adolescents: how low can you go? J Pediatr Adolesc Gynecol. 2010; 23: 195-201.
35. Nguyen-Pascal ML, Thomas JL, Bergougnoux L, Garnero P, Drapier-Faure E, Delmas PD,. Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period. Climacteric. 2005; 8: 136-45.